BRAF and neoplasm: Such an integrated final diagnosis in CNS-JXG neoplasms will allow for refinement of management with tailored treatment protocols and possible expansion of the spectrum of pediatric ECD, based on pathology, molecular and clinical/radiographic correlation in the post-BRAF era.